CCM
BMY.RT

Condor Capital Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Condor Capital Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,435
Closed -$7K – 285
2020
Q4 		$7K Sell
10,435
-51
-0.5% -$109 ﹤0.01% 190
2020
Q3 		$24K Sell
10,486
-128
-1% -$366 ﹤0.01% 178
2020
Q2 		$38K Sell
10,614
-202
-2% -$729 0.01% 180
2020
Q1 		$41K Sell
10,816
-138
-1% -$455 0.01% 165
2019
Q4 		$33K Buy
+10,954
New +$28.5K ﹤0.01% 181

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Condor Capital Management's BMY.RT Position: Q1 2021 in Review

Condor Capital Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 10,435 shares — an estimated $7K sold.

Condor Capital Management first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $41K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Condor Capital Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Condor Capital Management sold 10,435 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $7K.
  • Condor Capital Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Condor Capital Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $41K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Condor Capital Management's 13F filing for Q1 2021, filed 10 May 2021.